Ram Sasisekharan

Professor

Department
School of Engineering
Technology Areas
Biotechnology: Synthetic Biology, Biomanufacturing, DNA & RNA Editing / Diagnostics: Assays / Drug Discovery and Research Tools: Antibodies, Genomics & Proteomics, Cell Interrogation / Therapeutics: Proteins & Antibodies, Vaccines, Nucleic Acids, Small Molecules / Drug Delivery: Vectors & Virus like Particles / Chemicals & Materials: Nanotechnology & Nanomaterials

Technologies

Methods and Products Related to the Improved Analysis of Carbohydrates

Exclusively Licensed Technology / Case number: #11912J
Rahul Raman / Karthik Viswanathan / Aravind Srinivasan / Sasisekharan Raguram / Pankaj Gandhe / Carlos Bosques / Nishla Keiser / Ram Sasisekharan
Technology Areas: Biotechnology / Diagnostics / Drug Discovery and Research Tools
Impact Areas: Healthy Living

Novel Full Spectrum Anti-Dengue Antibody

Exclusively Licensed Technology / Case number: #16643
Ram Sasisekharan / Kannan Tharakaraman
Technology Areas: Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living

Molecular Determinants of Human Adaptation of H5N1 Influenza A Virus Hemagglutinin

Exclusively Licensed Technology / Case number: #14274
Rahul Raman / Kannan Tharakaraman / Karthik Viswanathan / Ram Sasisekharan
Technology Areas: Biotechnology / Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living

Rational Design of Affinity Improvement of Dengue 4e11 Antibody

Exclusively Licensed Technology / Case number: #15783
Ram Sasisekharan / Kannan Tharakaraman / Luke Robinson
Technology Areas: Diagnostics / Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living

Determinants of Human Receptor Specificity of Influenza A Virus H2N2 Hemagglutinin

Exclusively Licensed Technology / Case number: #14302
Rahul Raman / Xiaoying Koh / Karthik Viswanathan / Aarthi Chandrasekaran / Ram Sasisekharan
Technology Areas: Biotechnology / Diagnostics / Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living

Broad Neutralizing Antibodies to Groups 1 and 2 Influenza HA

Exclusively Licensed Technology / Case number: #15049
Ram Sasisekharan / Vidya Subramanian / Kannan Tharakaraman / Venkataramanan Soundararajan / Sasisekharan Raguram / Viswanathan Sasisekharan
Technology Areas: Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living

Natural Evolution of H5N1 Hemagglutinin Amino Acid Sequence and Its Implication on Human Adaptation and Antigenicity

Exclusively Licensed Technology / Case number: #16072
Rahul Raman / Nathan Stebbins / Kannan Tharakaraman / Karthik Viswanathan / Ram Sasisekharan
Technology Areas: Diagnostics / Therapeutics
Impact Areas: Healthy Living

Engineered Proteins for Targeted Full Spectrum Influenza Neutralization

Exclusively Licensed Technology / Case number: #13937
Ram Sasisekharan / Vidya Subramanian / Venkataramanan Soundararajan / Karthik Viswanathan / Sasisekharan Raguram / Viswanathan Sasisekharan
Technology Areas: Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living

Glycan-Binding Properties of the 2009 'Swine Flu' H1N1 Influenza A Virus Hemagglutinin and its Mutant Forms

Exclusively Licensed Technology / Case number: #13812
Rahul Raman / Akila Jayaraman / Karthik Viswanathan / Zachary Shriver / Ram Sasisekharan
Technology Areas: Diagnostics / Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living

Self Assembled RSV Nanoparticle Vaccines

Technology / Case number: #16549
Ram Sasisekharan / Aditya Raguram / Vidya Subramanian
Technology Areas: Chemicals & Materials / Therapeutics
Impact Areas: Healthy Living
License

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.